Literature DB >> 11483246

The cyclic AMP response element in the Bcl-2 promoter confers inducibility by hypoxia in neuronal cells.

K Freeland1, L M Boxer, D S Latchman.   

Abstract

In neuronal cells, expression of the anti-apoptotic Bcl-2 gene is induced by hypoxia and produces a protective effect. We show here that this effect is dependent upon the cyclic AMP response element (CRE) in the Bcl-2 promoter since mutation of this element abolishes the response and the isolated CRE can confer the response on a heterologous promoter. Interestingly however, the CRE in the Bcl-2 promoter does not render the promoter responsive to cyclic AMP and is not essential for its response to nerve growth factor. Despite the lack of cyclic AMP responsiveness, activation of the Bcl-2 promoter via the CRE in response to hypoxia requires the CREB transcription factor and is associated with the enhanced phosphorylation of CREB on serine 133 and enhanced transcriptional activation by the CREB-binding protein, CBP, in response to hypoxia. This finding establishes the importance of the CRE in the induction of Bcl-2 gene expression by hypoxia, allowing the Bcl-2 protein to protect neuronal cells against this damaging stimulus.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11483246     DOI: 10.1016/s0169-328x(01)00158-9

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  20 in total

Review 1.  T cell apoptosis and reactive oxygen species.

Authors:  David A Hildeman; Thomas Mitchell; John Kappler; Philippa Marrack
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

Review 2.  Oxygen sensing in neuroendocrine cells and other cell types: pheochromocytoma (PC12) cells as an experimental model.

Authors:  Zachary Spicer; David E Millhorn
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

Review 3.  Multiple pathways transmit neuroprotective effects of gonadal steroids.

Authors:  Damani N Bryant; Laird C Sheldahl; Lisa K Marriott; Robert A Shapiro; Daniel M Dorsa
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

4.  The aryl hydrocarbon receptor nuclear translocator is an essential regulator of murine hematopoietic stem cell viability.

Authors:  Bryan L Krock; Tzipora S Eisinger-Mathason; Dionysios N Giannoukos; Jessica E Shay; Mercy Gohil; David S Lee; Michael S Nakazawa; Julie Sesen; Nicolas Skuli; M Celeste Simon
Journal:  Blood       Date:  2015-04-08       Impact factor: 22.113

5.  Hypoxia induces a functionally significant and translationally efficient neuronal NO synthase mRNA variant.

Authors:  Michael E Ward; Mourad Toporsian; Jeremy A Scott; Hwee Teoh; Vasanthi Govindaraju; Adrian Quan; Avraham D Wener; Guilin Wang; Siân C Bevan; Derek C Newton; Philip A Marsden
Journal:  J Clin Invest       Date:  2005-11       Impact factor: 14.808

Review 6.  HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis.

Authors:  R N Saha; K Pahan
Journal:  Cell Death Differ       Date:  2006-04       Impact factor: 15.828

7.  Hypoxic adaptation engages the CBP/CREST-induced coactivator complex of Creb-HIF-1α in transactivating murine neuroblastic glucose transporter.

Authors:  Shanthie Thamotharan; Nupur Raychaudhuri; Masatoshi Tomi; Bo-Chul Shin; Sherin U Devaskar
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-01-15       Impact factor: 4.310

8.  CREB, a possible upstream regulator of Bcl-2 in trichosanthin-induced HeLa cell apoptosis.

Authors:  Ping Wang; Jin Xu; Cheng Zhang
Journal:  Mol Biol Rep       Date:  2009-07-21       Impact factor: 2.316

Review 9.  Combination treatment with progesterone and vitamin D hormone may be more effective than monotherapy for nervous system injury and disease.

Authors:  Milos Cekic; Iqbal Sayeed; Donald G Stein
Journal:  Front Neuroendocrinol       Date:  2009-04-24       Impact factor: 8.606

10.  Modulation of the cAMP signaling pathway after traumatic brain injury.

Authors:  Coleen M Atkins; Anthony A Oliva; Ofelia F Alonso; Damien D Pearse; Helen M Bramlett; W Dalton Dietrich
Journal:  Exp Neurol       Date:  2007-08-29       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.